HCA Healthcare
1,012 hedge funds and large institutions have $52.6B invested in HCA Healthcare in 2023 Q2 according to their latest regulatory filings, with 111 funds opening new positions, 322 increasing their positions, 419 reducing their positions, and 66 closing their positions.
68% more first-time investments, than exits
New positions opened: 111 | Existing positions closed: 66
14% more capital invested
Capital invested by funds: $46.3B → $52.6B (+$6.34B)
4% more funds holding
Funds holding: 970 → 1,012 (+42)
3% more call options, than puts
Call options by funds: $585M | Put options by funds: $567M
0.53% less ownership
Funds ownership: 63.59% → 63.05% (-0.53%)
10% less funds holding in top 10
Funds holding in top 10: 40 → 36 (-4)
23% less repeat investments, than reductions
Existing positions increased: 322 | Existing positions reduced: 419
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$513M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$426M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$305M |
| 4 |
Janus Henderson Group
London,
|
+$155M |
| 5 |
Man Group
London,
United Kingdom
|
+$145M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$619M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$538M |
| 3 |
Harris Associates
Chicago,
Illinois
|
-$535M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$203M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
-$163M |
HCA Hedge Fund Activity: Q2 2023 in Review
1,012 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in HCA Healthcare (HCA) for Q2 2023, worth a combined $52.6B — up 14% from $46.3B a quarter earlier.
Buyers outnumbered sellers: 111 funds opened new HCA positions and 66 closed out — a net gain of 45 holders — while 322 added to existing stakes and 419 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $513M. The largest seller was T. Rowe Price Associates, cutting an estimated $619M.
- 1,012 institutional investors held HCA Healthcare (HCA) as of Q2 2023, up from 970 in Q1 2023.
- Funds reported $52.6B of HCA Healthcare stock for Q2 2023, up 14% quarter-over-quarter.
- 111 funds opened new HCA Healthcare positions in Q2 2023 and 66 closed out, a net change of +45 holders.
- The largest HCA Healthcare buyer in Q2 2023 was Royal Bank of Canada, an estimated $513M added.
- The largest HCA Healthcare seller in Q2 2023 was T. Rowe Price Associates, an estimated $619M sold.
Based on aggregated 13F filings for Q2 2023.